Hereditary Cerebellar Ataxias: A Korean Perspective

Ji Sun Kim, Jin Whan Cho, Ji Sun Kim, Jin Whan Cho

Abstract

Hereditary ataxia is a heterogeneous disorder characterized by progressive ataxia combined with/without peripheral neuropathy, extrapyramidal symptoms, pyramidal symptoms, seizure, and multiple systematic involvements. More than 35 autosomal dominant cerebellar ataxias have been designated as spinocerebellar ataxia, and there are 55 recessive ataxias that have not been named systematically. Conducting genetic sequencing to confirm a diagnosis is difficult due to the large amount of subtypes with phenotypic overlap. The prevalence of hereditary ataxia can vary among countries, and estimations of prevalence and subtype frequencies are necessary for planning a diagnostic strategy in a specific population. This review covers the various hereditary ataxias reported in the Korean population with a focus on the prevalence and subtype frequencies as the clinical characteristics of the various subtypes.

Keywords: Cerebellar ataxia; Korea; Prevalence; Spinocerebellar ataxias.

Conflict of interest statement

Conflicts of Interest

The authors have no financial conflicts of interest.

References

    1. Brusse E, Maat-Kievit JA, van Swieten JC. Diagnosis and management of early- and late-onset cerebellar ataxia. Clin Genet. 2007;71:12–24.
    1. Fogel BL, Perlman S. Clinical features and molecular genetics of autosomal recessive cerebellar ataxias. Lancet Neurol. 2007;6:245–257.
    1. Holmes G. An attempt to classify cerebellar disease, with a note on Marie’s hereditary cerebellar ataxia. Brain. 1907;30:545–567.
    1. Greenfield JG. The Spinocerebellar Degenerations. Spring-field, IL: Charles C. Thomas; 1954.
    1. Harding AE. Classification of the hereditary ataxias and paraplegias. Lancet. 1983;1:1151–1155.
    1. Jayadev S, Bird TD. Hereditary ataxias: overview. Genet Med. 2013;15:673–683.
    1. Klockgether T. Update on degenerative ataxias. Curr Opin Neurol. 2011;24:339–345.
    1. Basu P, Chattopadhyay B, Gangopadhaya PK, Mukherjee SC, Sinha KK, Das SK, et al. Analysis of CAG repeats in SCA1, SCA2, SCA3, SCA6, SCA7 and DRPLA loci in spinocerebellar ataxia patients and distribution of CAG repeats at the SCA1, SCA2 and SCA6 loci in nine ethnic populations of eastern India. Hum Genet. 2000;106:597–604.
    1. Maruyama H, Izumi Y, Morino H, Oda M, Toji H, Nakamura S, et al. Difference in disease-free survival curve and regional distribution according to subtype of spinocerebellar ataxia: a study of 1,286 Japanese patients. Am J Med Genet. 2002;114:578–583.
    1. Nagaoka U, Suzuki Y, Kawanami T, Kurita K, Shikama Y, Honda K, et al. Regional differences in genetic subgroup frequency in hereditary cerebellar ataxia, and a morphometrical study of brain MR images in SCA1, MJD and SCA6. J Neurol Sci. 1999;164:187–194.
    1. Pujana MA, Corral J, Gratacòs M, Combarros O, Berciano J, Genís D, et al. Spinocerebellar ataxias in Spanish patients: genetic analysis of familial and sporadic cases. The Ataxia Study Group. Hum Genet. 1999;104:516–522.
    1. Ranum LP, Lundgren JK, Schut LJ, Ahrens MJ, Perlman S, Aita J, et al. Spinocerebellar ataxia type 1 and Machado-Joseph disease: incidence of CAG expansions among adult-onset ataxia patients from 311 families with dominant, recessive, or sporadic ataxia. Am J Hum Genet. 1995;57:603–608.
    1. Durr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol. 2010;9:885–894.
    1. Tsoi H, Yu AC, Chen ZS, Ng NK, Chan AY, Yuen LY, et al. A novel missense mutation in CCDC88C activates the JNK pathway and causes a dominant form of spinocerebellar ataxia. J Med Genet. 2014;51:590–595.
    1. Cadieux-Dion M, Turcotte-Gauthier M, Noreau A, Martin C, Meloche C, Gravel M, et al. Expanding the clinical phenotype associated with ELOVL4 mutation: study of a large French-Canadian family with autosomal dominant spinocerebellar ataxia and erythrokeratodermia. JAMA Neurol. 2014;71:470–475.
    1. Storey E. Genetic cerebellar ataxias. Semin Neurol. 2014;34:280–292.
    1. Stevanin G, Dürr A, Brice A. Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology. Eur J Hum Genet. 2000;8:4–18.
    1. Pearson CE, Nichol Edamura K, Cleary JD. Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet. 2005;6:729–742.
    1. Moseley ML, Zu T, Ikeda Y, Gao W, Mosemiller AK, Daughters RS, et al. Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet. 2006;38:758–769.
    1. Chen WL, Lin JW, Huang HJ, Wang SM, Su MT, Lee-Chen GJ, et al. SCA8 mRNA expression suggests an antisense regulation of KLHL1 and correlates to SCA8 pathology. Brain Res. 2008;1233:176–184.
    1. van Gaalen J, Giunti P, van de Warrenburg BP. Movement disorders in spinocerebellar ataxias. Mov Disord. 2011;26:792–800.
    1. Giunti P, Sabbadini G, Sweeney MG, Davis MB, Veneziano L, Mantuano E, et al. The role of the SCA2 trinucleotide repeat expansion in 89 autosomal dominant cerebellar ataxia families. Frequency, clinical and genetic correlates. Brain. 1998;121(Pt 3):459–467.
    1. Ross OA, Rutherford NJ, Baker M, Soto-Ortolaza AI, Carrasquillo MM, DeJesus-Hernandez M, et al. Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet. 2011;20:3207–3212.
    1. Van Damme P, Veldink JH, van Blitterswijk M, Corveleyn A, van Vught PW, Thijs V, et al. Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology. 2011;76:2066–2072.
    1. Lima L, Coutinho P. Clinical criteria for diagnosis of Machado-Joseph disease: report of a non-Azorena Portuguese family. Neurology. 1980;30:319–322.
    1. Kim JS, Kim JS, Youn J, Seo DW, Jeong Y, Kang JH, et al. Ocular motor characteristics of different subtypes of spinocerebellar ataxia: distinguishing features. Mov Disord. 2013;28:1271–1277.
    1. Lee JY, Lee WW, Kim JS, Kim HJ, Kim JK, Jeon BS. Perverted head-shaking and positional downbeat nystagmus in patients with multiple system atrophy. Mov Disord. 2009;24:1290–1295.
    1. David G, Dürr A, Stevanin G, Cancel G, Abbas N, Benomar A, et al. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7) Hum Mol Genet. 1998;7:165–170.
    1. Rolfs A, Koeppen AH, Bauer I, Bauer P, Buhlmann S, Topka H, et al. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17) Ann Neurol. 2003;54:367–375.
    1. Nagafuchi S, Yanagisawa H, Sato K, Shirayama T, Ohsaki E, Bundo M, et al. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet. 1994;6:14–18.
    1. Tsuji S. Dentatorubral-pallidoluysian atrophy. Handb Clin Neurol. 2012;103:587–594.
    1. Ikeuchi T, Koide R, Tanaka H, Onodera O, Igarashi S, Takahashi H, et al. Dentatorubral-pallidoluysian atrophy: clinical features are closely related to unstable expansions of trinucleotide (CAG) repeat. Ann Neurol. 1995;37:769–775.
    1. Brunetti-Pierri N, Wilfong AA, Hunter JV, Craigen WJ. A severe case of dentatorubro-pallidoluysian atrophy (DRPLA) with microcephaly, very early onset of seizures, and cerebral white matter involvement. Neuropediatrics. 2006;37:308–311.
    1. Yoon WT, Youn J, Cho JW. Is cerebral white matter involvement helpful in the diagnosis of dentatorubral-pallidoluysian atrophy? J Neurol. 2012;259:1694–1697.
    1. Ruano L, Melo C, Silva MC, Coutinho P. The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology. 2014;42:174–183.
    1. van de Warrenburg BP, Sinke RJ, Verschuuren-Bemelmans CC, Scheffer H, Brunt ER, Ippel PF, et al. Spinocerebellar ataxias in the Netherlands: prevalence and age at onset variance analysis. Neurology. 2002;58:702–708.
    1. Rosenberg RN. Machado-Joseph disease: an autosomal dominant motor system degeneration. Mov Disord. 1992;7:193–203.
    1. de Castilhos RM, Furtado GV, Gheno TC, Schaeffer P, Russo A, Barsottini O, et al. Spinocerebellar ataxias in Brazil-- frequencies and modulating effects of related genes. Cerebellum. 2014;13:17–28.
    1. Vale J, Bugalho P, Silveira I, Sequeiros J, Guimarães J, Coutinho P. Autosomal dominant cerebellar ataxia: frequency analysis and clinical characterization of 45 families from Portugal. Eur J Neurol. 2010;17:124–128.
    1. Schöls L, Amoiridis G, Büttner T, Przuntek H, Epplen JT, Riess O. Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes? Ann Neurol. 1997;42:924–932.
    1. Tang B, Liu C, Shen L, Dai H, Pan Q, Jing L, et al. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds. Arch Neurol. 2000;57:540–544.
    1. Basri R, Yabe I, Soma H, Sasaki H. Spectrum and prevalence of autosomal dominant spinocerebellar ataxia in Hokkaido, the northern island of Japan: a study of 113 Japanese families. J Hum Genet. 2007;52:848–855.
    1. Polo JM, Calleja J, Combarros O, Berciano J. Hereditary ataxias and paraplegias in Cantabria, Spain. An epidemiological and clinical study. Brain. 1991;114(Pt 2):855–866.
    1. Leone M, Bottacchi E, D’Alessandro G, Kustermann S. Hereditary ataxias and paraplegias in Valle d’Aosta, Italy: a study of prevalence and disability. Acta Neurol Scand. 1995;91:183–187.
    1. Saleem Q, Choudhry S, Mukerji M, Bashyam L, Padma MV, Chakravarthy A, et al. Molecular analysis of autosomal dominant hereditary ataxias in the Indian population: high frequency of SCA2 and evidence for a common founder mutation. Hum Genet. 2000;106:179–187.
    1. Orozco G, Estrada R, Perry TL, Araña J, Fernandez R, Gonzalez-Quevedo A, et al. Dominantly inherited olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological, and biochemical findings. J Neurol Sci. 1989;93:37–50.
    1. Matsumura R, Futamura N, Ando N, Ueno S. Frequency of spinocerebellar ataxia mutations in the Kinki district of Japan. Acta Neurol Scand. 2003;107:38–41.
    1. Joo BE, Lee CN, Park KW. Prevalence rate and functional status of cerebellar ataxia in Korea. Cerebellum. 2012;11:733–738.
    1. Kim JY, Park SS, Joo SI, Kim JM, Jeon BS. Molecular analysis of Spinocerebellar ataxias in Koreans: frequencies and reference ranges of SCA1, SCA2, SCA3, SCA6, and SCA7. Mol Cells. 2001;12:336–341.
    1. Lee WY, Jin DK, Oh MR, Lee JE, Song SM, Lee EA, et al. Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients. Arch Neurol. 2003;60:858–863.
    1. Jin DK, Oh MR, Song SM, Koh SW, Lee M, Kim GM, et al. Frequency of spinocerebellar ataxia types 1,2,3,6,7 and dentatorubral pallidoluysian atrophy mutations in Korean patients with spinocerebellar ataxia. J Neurol. 1999;246:207–210.
    1. Kim JM, Shin S, Kim JY, Joo SI, Park SS, Kim JW, et al. Spinocerebellar ataxia type 2 in seven Korean families: CAG trinucleotide expansion and clinical characteristics. J Korean Med Sci. 1999;14:659–664.
    1. Kim HJ, Jeon BS, Lee WY, Chung SJ, Yong SW, Kang JH, et al. SCA in Korea and its regional distribution: a multicenter analysis. Parkinsonism Relat Disord. 2011;17:72–75.
    1. Heo JH, Bang OY, Moon JS, Sunwoo IN, Kim TS. A case of friedreich’s ataxia with optic atrophy as an initial? clinical manifestation. Korean J Neurology. 1994;12:562–565.
    1. Lee SA, Sunwoo IN, Kim KW. Electrophysiological studies in a case of friedreich’s ataxia. Korean J Neurology. 1986;4:137–141.
    1. Jeong H, Huh HJ, Youn J, Kim JS, Cho JW, Ki CS. Ataxiatelangiectasia with novel splicing mutations in the ATM gene. Ann Lab Med. 2014;34:80–84.
    1. Huh HJ, Cho KH, Lee JE, Kwon MJ, Ki CS, Lee PH. Identification of ATM mutations in Korean siblings with ataxiatelangiectasia. Ann Lab Med. 2013;33:217–220.
    1. Song MH, Kim EJ, Sung TJ, Shin SH, Lee KH, Kim HD. A case of progressive elevation of serum gamma-GTP level in ataxia-telangiectasia. J Korean Child Neurol Soc. 2006;14:363–368.
    1. Kang DW, Ahn SS, Jeon BS. A case of ataxia telangiectasia. J Korean Neurol Assoc. 1997;15:895–899.
    1. Hwang SY, Lee KH, Ahn JI. Cerebrotendinous xanthomatosis. J Dermatol. 1990;17:115–119.
    1. Suh S, Kim HK, Park HD, Ki CS, Kim MY, Jin SM, et al. Three siblings with Cerebrotendinous Xanthomatosis: a novel mutation in the CYP27A1 gene. Eur J Med Genet. 2012;55:71–74.
    1. Ehm G, Yang HJ, Kim HJ, Jeon BS. The first case report of fragile X-associated tremor ataxia syndrome in the Republic of Korea. Neurology Asia. 2014;19:99–103.
    1. Kim HS. Social integration and heath policy issues for international marriage migrant women in South Korea. Public Health Nurs. 2010;27:561–570.
    1. HUGO Pan-Asian SNP Consortium, Abdulla MA, Ahmed I, Assawamakin A, Bhak J, Brahmachari SK, et al. Mapping human genetic diversity in Asia. Science. 2009;326:1541–1545.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera